Literature DB >> 20130282

Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes.

Hille W van Dijk1, Frank D Verbraak, Pauline H B Kok, Mona K Garvin, Milan Sonka, Kyungmoo Lee, J Hans Devries, Robert P J Michels, Mirjam E J van Velthoven, Reinier O Schlingemann, Michael D Abràmoff.   

Abstract

PURPOSE. To determine which retinal layers are most affected by diabetes and contribute to thinning of the inner retina and to investigate the relationship between retinal layer thickness (LT) and diabetes duration, diabetic retinopathy (DR) status, age, glycosylated hemoglobin (HbA1c), and the sex of the individual, in patients with type 1 diabetes who have no or minimal DR. METHODS. Mean LT was calculated for the individual retinal layers after automated segmentation of spectral domain-optical coherence tomography scans of patients with diabetes and compared with that in control subjects. Multiple linear regression analysis was used to determine the relationship between LT and HbA1c, age, sex, diabetes duration, and DR status. RESULTS. In patients with minimal DR, the mean ganglion cell layer (GCL) in the pericentral area was 5.1 mum thinner (95% confidence interval [CI], 1.1-9.1 mum), and in the peripheral macula, the mean retinal nerve fiber layer (RNFL) was 3.7 mum thinner (95% CI, 1.3-6.1 mum) than in the control subjects. There was a significant linear correlation (R = 0.53, P < 0.01) between GCL thickness and diabetes duration in the pooled group of patients. Multiple linear regression analysis (R = 0.62, P < 0.01) showed that DR status was the most important explanatory variable. CONCLUSIONS. This study demonstrates GCL thinning in the pericentral area and corresponding loss of RNFL thickness in the peripheral macula in patients with type 1 diabetes and no or minimal DR compared with control subjects. These results support the concept that diabetes has an early neurodegenerative effect on the retina, which occurs even though the vascular component of DR is minimal.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20130282      PMCID: PMC2904016          DOI: 10.1167/iovs.09-5041

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  35 in total

1.  Multifocal electroretinogram delays reveal local retinal dysfunction in early diabetic retinopathy.

Authors:  B Fortune; M E Schneck; A J Adams
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-10       Impact factor: 4.799

2.  Decreased optical coherence tomography-measured pericentral retinal thickness in patients with diabetes mellitus type 1 with minimal diabetic retinopathy.

Authors:  Carine Biallosterski; Mirjam E J van Velthoven; Robert P J Michels; Reinier O Schlingemann; J Hans DeVries; Frank D Verbraak
Journal:  Br J Ophthalmol       Date:  2007-03-23       Impact factor: 4.638

3.  Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.

Authors:  A J Barber; E Lieth; S A Khin; D A Antonetti; A G Buchanan; T W Gardner
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

4.  Local diabetic retinopathy prediction by multifocal ERG delays over 3 years.

Authors:  Jason S Ng; Marcus A Bearse; Marilyn E Schneck; Shirin Barez; Anthony J Adams
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

5.  Early detection of macular changes in patients with diabetes using Rarebit Fovea Test and optical coherence tomography.

Authors:  M Nilsson; G von Wendt; P Wanger; L Martin
Journal:  Br J Ophthalmol       Date:  2007-06-25       Impact factor: 4.638

6.  Adolescents with Type 2 diabetes: early indications of focal retinal neuropathy, retinal thinning, and venular dilation.

Authors:  Kevin W Bronson-Castain; Marcus A Bearse; Jessica Neuville; Soffia Jonasdottir; Barbara King-Hooper; Shirin Barez; Marilyn E Schneck; Anthony J Adams
Journal:  Retina       Date:  2009-05       Impact factor: 4.256

7.  Changes of macular and RNFL thicknesses measured by Stratus OCT in patients with early stage diabetes.

Authors:  T Oshitari; K Hanawa; E Adachi-Usami
Journal:  Eye (Lond)       Date:  2008-04-25       Impact factor: 3.775

8.  Macular thickness and systemic markers for diabetes in individuals with no or mild diabetic retinopathy.

Authors:  Baharak Asefzadeh; Barry M Fisch; Chad E Parenteau; Anthony A Cavallerano
Journal:  Clin Exp Ophthalmol       Date:  2008-07       Impact factor: 4.207

9.  Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2 Akita diabetic mice.

Authors:  Matthew J Gastinger; Allen R Kunselman; Erin E Conboy; Sarah K Bronson; Alistair J Barber
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06       Impact factor: 4.799

10.  Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy.

Authors:  Hille W van Dijk; Pauline H B Kok; Mona Garvin; Milan Sonka; J Hans Devries; Robert P J Michels; Mirjam E J van Velthoven; Reinier O Schlingemann; Frank D Verbraak; Michael D Abràmoff
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-17       Impact factor: 4.799

View more
  125 in total

1.  Ratiometric analysis of optical coherence tomography-measured in vivo retinal layer thicknesses for the detection of early diabetic retinopathy.

Authors:  Basanta Bhaduri; Ryan L Shelton; Ryan M Nolan; Lucas Hendren; Alexandra Almasov; Leanne T Labriola; Stephen A Boppart
Journal:  J Biophotonics       Date:  2017-06-21       Impact factor: 3.207

2.  Neuroretinal alterations in the early stages of diabetic retinopathy in patients with type 2 diabetes mellitus.

Authors:  P Carpineto; L Toto; R Aloia; V Ciciarelli; E Borrelli; E Vitacolonna; M Di Nicola; L Di Antonio; R Mastropasqua
Journal:  Eye (Lond)       Date:  2016-02-12       Impact factor: 3.775

Review 3.  Retinal imaging and image analysis.

Authors:  Michael D Abràmoff; Mona K Garvin; Milan Sonka
Journal:  IEEE Rev Biomed Eng       Date:  2010

Review 4.  Diabetic retinopathy is a neurodegenerative disorder.

Authors:  Stephanie K Lynch; Michael D Abràmoff
Journal:  Vision Res       Date:  2017-04-28       Impact factor: 1.886

5.  Systemic Determinants of Peripapillary Vessel Density in Healthy African Americans: The African American Eye Disease Study.

Authors:  Ryuna Chang; Andrew J Nelson; Vivian LeTran; Brian Vu; Bruce Burkemper; Zhongdi Chu; Ali Fard; Amir H Kashani; Benjamin Y Xu; Ruikang K Wang; Rohit Varma; Grace M Richter
Journal:  Am J Ophthalmol       Date:  2019-06-21       Impact factor: 5.258

Review 6.  Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies.

Authors:  Sidra Zafar; Mira Sachdeva; Benjamin J Frankfort; Roomasa Channa
Journal:  Curr Diab Rep       Date:  2019-02-26       Impact factor: 4.810

7.  Effect of age on individual retinal layer thickness in normal eyes as measured with spectral-domain optical coherence tomography.

Authors:  Nazli Demirkaya; Hille W van Dijk; Sanne M van Schuppen; Michael D Abràmoff; Mona K Garvin; Milan Sonka; Reinier O Schlingemann; Frank D Verbraak
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-22       Impact factor: 4.799

Review 8.  Diabetic retinopathy: current understanding, mechanisms, and treatment strategies.

Authors:  Elia J Duh; Jennifer K Sun; Alan W Stitt
Journal:  JCI Insight       Date:  2017-07-20

9.  Cone Photoreceptor Dysfunction in Early-Stage Diabetic Retinopathy: Association Between the Activation Phase of Cone Phototransduction and the Flicker Electroretinogram.

Authors:  J Jason McAnany; Jason C Park
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-01-02       Impact factor: 4.799

10.  The effects of early diabetes on inner retinal neurons.

Authors:  Erika D Eggers; Teresia A Carreon
Journal:  Vis Neurosci       Date:  2020-09-16       Impact factor: 3.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.